FI95871B - Förfarande för framställning av en HIV-partikelimmunogen och dess antikropp - Google Patents

Förfarande för framställning av en HIV-partikelimmunogen och dess antikropp

Info

Publication number
FI95871B
FI95871B FI890603A FI890603A FI95871B FI 95871 B FI95871 B FI 95871B FI 890603 A FI890603 A FI 890603A FI 890603 A FI890603 A FI 890603A FI 95871 B FI95871 B FI 95871B
Authority
FI
Finland
Prior art keywords
immunogen
hiv
retrovirus
infectious
useful
Prior art date
Application number
FI890603A
Other languages
English (en)
Finnish (fi)
Other versions
FI95871C (sv
FI890603A0 (sv
FI890603A (sv
Inventor
Jonas Salk
Dennis J Carlo
Original Assignee
Immune Response Corp Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Response Corp Inc filed Critical Immune Response Corp Inc
Publication of FI890603A0 publication Critical patent/FI890603A0/sv
Publication of FI890603A publication Critical patent/FI890603A/sv
Application granted granted Critical
Publication of FI95871B publication Critical patent/FI95871B/sv
Publication of FI95871C publication Critical patent/FI95871C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
FI890603A 1987-06-10 1989-02-08 Förfarande för framställning av en HIV-partikelimmunogen och dess antikropp FI95871C (sv)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US6028087A 1987-06-10 1987-06-10
US6028087 1987-06-10
US20075288A 1988-05-31 1988-05-31
US20075288 1988-05-31
PCT/US1988/001955 WO1988009670A1 (en) 1987-06-10 1988-06-09 Prevention and treatment of retroviral disease
US8801955 1988-06-09

Publications (4)

Publication Number Publication Date
FI890603A0 FI890603A0 (sv) 1989-02-08
FI890603A FI890603A (sv) 1989-02-08
FI95871B true FI95871B (sv) 1995-12-29
FI95871C FI95871C (sv) 1996-04-10

Family

ID=26739775

Family Applications (1)

Application Number Title Priority Date Filing Date
FI890603A FI95871C (sv) 1987-06-10 1989-02-08 Förfarande för framställning av en HIV-partikelimmunogen och dess antikropp

Country Status (14)

Country Link
EP (3) EP0685236A1 (sv)
JP (1) JPH0720880B2 (sv)
AT (1) ATE132374T1 (sv)
AU (1) AU612383B2 (sv)
CA (1) CA1336407C (sv)
DE (1) DE3854857T2 (sv)
DK (1) DK56389D0 (sv)
FI (1) FI95871C (sv)
IL (1) IL86675A (sv)
NO (1) NO175846C (sv)
OA (1) OA09037A (sv)
RU (1) RU2111010C1 (sv)
UA (1) UA27716C2 (sv)
WO (1) WO1988009670A1 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01502751A (ja) * 1987-03-23 1989-09-21 ハイヴァー　リミテッド 新規ワクチン類
US5256767A (en) * 1987-06-10 1993-10-26 The Immune Response Corporation Retroviral antigens
US5227159A (en) * 1989-01-31 1993-07-13 Miller Richard A Anti-idiotype antibodies reactive with shared idiotopes expressed by B cell lymphomas and autoantibodies
DE69029135T2 (de) * 1989-05-30 1997-05-28 Nippon Zeon Co Verfahren zur herstellung von kernstrukturen von retroviren und dadurch hergestellte partikel
FR2661834B1 (fr) * 1990-05-09 1995-01-27 Merieux Inst Procede de fabrication d'immunogenes de retrovirus et de vaccins contre les infections retrovirales, notamment hiv, et immunogenes et vaccins obtenus.
WO1994002171A1 (en) * 1992-07-20 1994-02-03 The Immune Response Corporation Prophylactic and therapeutic control of retroviral infections
JP3313117B2 (ja) * 1994-03-22 2002-08-12 ザ イミューン リスポンス コーポレイション ウイルス粒子の効率の高い生産および単離
IT1271593B (it) * 1994-11-30 1997-06-04 Sanitaria Scaligera Spa Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716102A (en) * 1984-08-15 1987-12-29 Regents Of The University Of California Purified AIDS-associated virus ARV-2
DK507185A (da) * 1984-11-05 1986-05-06 Du Pont Fremgangsmaade til inaktivering af human tumor leukaemi virus iii
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III
AU600658B2 (en) * 1984-12-24 1990-08-23 Genentech Inc. Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
WO1986006099A1 (en) * 1985-04-08 1986-10-23 Genetic Systems Corporation EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV
FI861626A (fi) * 1985-04-19 1986-10-20 Hoffmann La Roche Foervaervat immunbristsyndrom (aids) -relaterat viralt rekombinant hoeljeprotein samt ett testfoerfarande foer aids.
EP0249611A4 (en) * 1985-11-14 1988-04-26 Harvard College T-LYMPHOTROPHIC VIRUS.
EP0250128A3 (en) * 1986-06-18 1988-06-08 American Registry of Pathology Novel virus isolated from patients with aids
CA1341277C (en) * 1987-03-16 2001-07-31 Roland Keith Mcgready Anti-paratopic antibody and a method of its manufacture

Also Published As

Publication number Publication date
UA27716C2 (uk) 2000-10-16
ATE132374T1 (de) 1996-01-15
EP0685236A1 (en) 1995-12-06
DK56389A (da) 1989-02-08
FI95871C (sv) 1996-04-10
JPH02500440A (ja) 1990-02-15
FI890603A0 (sv) 1989-02-08
EP0317622A4 (en) 1990-05-14
DE3854857D1 (de) 1996-02-15
NO890565L (no) 1989-02-09
EP0317622A1 (en) 1989-05-31
DK56389D0 (da) 1989-02-08
FI890603A (sv) 1989-02-08
EP0317622B1 (en) 1996-01-03
AU612383B2 (en) 1991-07-11
NO890565D0 (no) 1989-02-09
DE3854857T2 (de) 1996-08-22
WO1988009670A1 (en) 1988-12-15
EP0602761A1 (en) 1994-06-22
AU1962688A (en) 1989-01-04
RU2111010C1 (ru) 1998-05-20
IL86675A (en) 1993-04-04
CA1336407C (en) 1995-07-25
JPH0720880B2 (ja) 1995-03-08
OA09037A (en) 1991-03-31
NO175846B (sv) 1994-09-12
NO175846C (no) 1994-12-21

Similar Documents

Publication Publication Date Title
DK0778888T3 (da) Antigen-mærket ikke-infektiös retroviruslignende partikel
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
RU94042386A (ru) Вакцина против гепатита, содержащая 3-0-дезацилированный монофосфорил-липида, применение антигена гепатита для получения препарата для лечения гепатита, способ лечения гепатита
CA2102918A1 (en) Genetic vaccine for immunodeficiency viruses
AU2684792A (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
ATE397014T1 (de) Hiv-peptide, antigene und impfstoffzusammensetzungen
WO2002020554A3 (en) Hiv peptides from conserved regions in gag p17 and 924 and their application in e.g. vaccines
FI95871B (sv) Förfarande för framställning av en HIV-partikelimmunogen och dess antikropp
HUP0104881A2 (hu) Eljárás inaktivált "víz az olajban" emulzióval adjuvált vakcinák előállítására
ATE188484T1 (de) Immunologisch mit hla homologe hiv protein epitope
ATE105938T1 (de) Monoklonale antikörper gegen spezifische antigene regionen des humanen immundefizienzvirus und methoden zur verwendung.
NZ222766A (en) Aids virus antigens: env/gag polypeptides: production by genetic engineering techniques: vaccines, and methods of diagnostic testing
SE8701765L (sv) Analysmetod och medel foer denna
HUP0003511A2 (hu) Hepatitisz-B-vírus polipeptidek
EP0309898A3 (en) Method for the induction of a cytotoxic t cell response
PT90800A (pt) Processo para a preparacao de antigenios precursores das glicoproteinas de involucro de um retrovirus humano hiv-2 e de antigenios que apresentem uma analogia imonulogiga com estes ultimos e sua aplicacao ao diagnostico
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
AU6791290A (en) Antigens relating to envelope glyoprotein of the virus of aids, particularly precursors of this glycoprotein, methods of obtaining these antigens and means employed in these methods, applications of these antigens in the preparation of immunogenic compositions or for the diagnosis of aids or

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: THE IMMUNE RESPONSE CORPORATION, INC.

MA Patent expired